Evaluating a new stentgraft for aortic arch conditions
Outcome of a Triple Inner Branched Aortic Arch Stentgraft. A Prospective, Multicenter Registry.
This study is testing a new type of stent for people with aortic arch problems to see how well it works and how safe it is.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30 (estimated) |
| Sex | All |
| Sponsor | University Hospital Muenster Academic / other |
| Locations | 1 site (Münster) |
| Trial ID | NCT05530304 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the outcomes of a triple inner branched aortic arch stentgraft in patients with aortic arch pathologies. It involves a multicenter registry approach, collecting data from various sites to evaluate the effectiveness and safety of the stentgraft. Patients aged 18 and older who have specific aortic arch conditions and are scheduled for treatment with this stentgraft will be included in the study. The study will follow patients over time to monitor their progress and outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older with a diagnosed aortic arch pathology who are scheduled to receive treatment with the triple inner branch stentgraft.
Not a fit: Patients under 18 years old and women of childbearing age are excluded and may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a new treatment option for patients with complex aortic arch conditions, potentially improving their outcomes.
How similar studies have performed: While this specific approach is novel, similar studies evaluating stentgrafts for aortic arch conditions have shown promising results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years or older * Presence of Aortic arch pathology * Treatment planned with triple inner branch from Terumo Aortic * Availability of the patients during the follow up period * Informing patients about the study and providing written informed consent Exclusion Criteria: * Women of childbearing age * Patients under 18 years
Where this trial is running
Münster
- Muenster University Hospital — Münster, Germany (Recruiting)
Study contacts
- Study coordinator: Alexander Oberhuber, MD, PhD
- Email: alexander.oberhuber@ukmuenster.de
- Phone: +49 251 8345781
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.